Table 4 Distributions of SCAP and SREBF-2 genotypes among men with SCD, AMI, thrombosis and complicated lesions (CL), and among those who had not suffered from the same at the time of death
Genotype | N (%) | N (%) | N (%) | N (%) | |||||
|---|---|---|---|---|---|---|---|---|---|
SCAP | SREBF-2 | SCD | Non-SCD | With CL | Without CL | Thrombus | Without thrombus | AMI | Non-AMI |
AA | GC+CC | 8 (8.4) | 26 (17.1) | 8 (8.8) | 26 (16.7) | 2 (10.0) | 32 (14.1) | 4 (14.3) | 30 (13.7) |
GG | 21 (22.1) | 30 (19.7) | 18 (19.8) | 33 (21.2) | 2 (10.0) | 49 (21.6) | 3 (10.7) | 48 (21.9) | |
AG+GG | GC+CC | 33 (34.7) | 40 (26.3) | 31 (34.1) | 42 (26.9) | 8 (40.0) | 65 (28.6) | 11 (39.3) | 62 (28.3) |
GG | 33 (34.7) | 56 (36.8) | 34 (37.4) | 55 (35.3) | 8 (40.0) | 81 (35.7) | 10 (35.7) | 79 (36.1) | |